Products for Research Use Only
RegisterLogin

GSK256066 (Standard)

CAT: 0804-HY-10469R-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10469R-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
GSK256066 (Standard) is the analytical standard of GSK256066. This product is intended for research and analytical applications. GSK256066 is a selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor, with an IC50 of 3.2 pM for PDE4B. GSK256066 is developed for the research of chronic obstructive pulmonary disease[1].
CAS Number
801312-28-7
UNSPSC
12352005
Target
Phosphodiesterase (PDE) ; Reference Standards
Related Pathways
Metabolic Enzyme/Protease; Others
Field of Research
Inflammation/Immunology
Smiles
O=C(N)C1=C(C2=CC(S(=O)(C3=CC=CC(C(N(C)C)=O)=C3)=O)=CC(C)=C2N=C1)NC4=CC=CC(OC)=C4
Molecular Formula
C27H26N4O5S
Molecular Weight
518.58
References & Citations
[1]Tralau-Stewart CJ, et al. GSK256066, an exceptionally high-affinity and selective inhibitor of phosphodiesterase 4 suitable for administration by inhalation: in vitro, kinetic, and in vivo characterization. J Pharmacol Exp Ther, 2011, 337 (1), 145-154.|[2]Nials AT, et al. In vivo characterization of GSK256066, a high-affinity inhaled phosphodiesterase 4 inhibitor. J Pharmacol Exp Ther, 2011, 337 (1), 137-144.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards

Chemical Information

Gsk-256066

GSK-256066 is gsk256066 has been used in trials studying the treatment and diagnostic of SAR, Asthma, Mild Asthma, Allergic Rhinitis, and Seasonal Allergic Rhinitis, among others.

CAS Number801312-28-7
PubChem CID9827968
IUPAC Name6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide
Molecular FormulaC27H26N4O5S
Molecular Weight518.6
XLogP3.8
Topological Polar Surface Area140
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Heavy Atom Count37
Formal Charge0
Complexity922
SMILES
CC1=CC(=CC2=C(C(=CN=C12)C(=O)N)NC3=CC(=CC=C3)OC)S(=O)(=O)C4=CC=CC(=C4)C(=O)N(C)C
InChI
InChI=1S/C27H26N4O5S/c1-16-11-21(37(34,35)20-10-5-7-17(12-20)27(33)31(2)3)14-22-24(16)29-15-23(26(28)32)25(22)30-18-8-6-9-19(13-18)36-4/h5-15H,1-4H3,(H2,28,32)(H,29,30)
InChIKey
JFHROPTYMMSOLG-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Gsk-256066
CAS: 801312-28-7
CID: 9827968
Formula: C27H26N4O5S
MW: 518.6
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight518.6
XLogP33.8
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass518.16239112
Monoisotopic Mass518.16239112
Topological Polar Surface Area140 Ų
Heavy Atom Count37
Formal Charge0
Complexity922
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
HY-70069R-01GSK256066 (Trifluoroacetate) (Standard)
HY-10469-01GSK256066
HY-70069-01GSK256066 (Trifluoroacetate)
HY-Y0698R-01Thioacetamide (Standard)
HY-Y0061R-01Oxindole (Standard)
HY-W380450R-01Viloxazine (Standard)
HY-W376701R-01Guanadrel (Standard)
HY-W269867RTetratriacontane (Standard)
HY-W130610R-01Stearamide (Standard)
HY-W127565RHexatetracontane (Standard)

Alternative Products

CatalogName
WGC308144-10mgGSK256066
A11073-100GSK256066 100mg
A11073-50GSK256066 50mg
A11073-25GSK256066 25mg
A11073-10GSK256066 10mg

Popular Products